(Washington, June 12, 2017) – LUNGevity, the nation’s leading lung cancer-focused nonprofit, has been awarded the prestigious four-star rating from Charity Navigator, the nation’s most trusted charity evaluator. A four-star rating is the highest possible score, earned only by charities that prove to be transparent, reliable, and fiscally responsible.
“LUNGevity Foundation’s exceptional 4-star rating sets it apart from its peers and demonstrates its trustworthiness to the public,” according to Michael Thatcher, President & CEO of Charity Navigator. “Only a quarter of charities rated by Charity Navigator receive the distinction of our 4-star rating. This adds LUNGevity to a preeminent group of charities working to overcome our world’s most pressing challenges. Based on its 4-star rating, people can trust that their donations are going to a financially responsible and ethical charity when they decide to support LUNGevity.”
“We are honored to be given this significant recognition by Charity Navigator,” said Andrea Ferris, president of LUNGevity Foundation. “With our top rating of four stars, donors can be confident that we will be efficient, effective, and transparent stewards of their contributions, as we work together to create a world where no one dies of lung cancer.”
Visit LUNGevity’s Charity Navigator profile here.
About LUNGevity Foundation
LUNGevity is the nation's leading lung cancer organization investing in lifesaving, translational research and providing support services and education for patients and caregivers. LUNGevity’s goals are three-fold: (1) accelerate research to patients, (2) empower patients to be active participants in their treatment decisions, and (3) remove barriers that patients face in accessing the right treatments.
LUNGevity Foundation is firmly committed to making an immediate impact on increasing quality of life and survivorship of people with lung cancer by accelerating research into early detection and more effective treatments, as well as by providing community, support, and education for all those affected by the disease. LUNGevity’s comprehensive resources include a medically vetted website, a toll-free HELPLine in partnership with CancerCare®, a unique Lung Cancer Navigator app, peer-to-peer mentoring for patients and caregivers (LUNGevity LifeLine), and survivorship conferences. LUNGevity also helps patients find and navigate clinical trials through our Clinical Trial Finder tool, a Clinical Trial Ambassador program, and participation with EmergingMed.
For more information about LUNGevity Foundation, please visit www.LUNGevity.org.
About Lung Cancer
- 1 in 16 Americans will be diagnosed with lung cancer in their lifetime
- More than 222,000 people in the U.S. will be diagnosed with lung cancer this year
- About 60%-65% of all new lung cancer diagnoses are among people who have never smoked or are former smokers
- Lung cancer takes more lives than the next three leading cancers (colorectal, breast, and prostate) combined
- Only 18% of all people diagnosed with lung cancer will survive 5 years or more, BUT if it’s caught before it spreads, the chance for 5-year survival improves dramatically